NCT04231136View on ClinicalTrials.gov

Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

July 29, 2020

Study Completion Date

August 3, 2020

Conditions
Healthy
Interventions
DRUG

Tegoprazan 50 mg

Tegoprazan 50 mg tablet

DRUG

EAPA115

EAPA115

DRUG

RAPA115

RAPA115

Trial Locations (1)

Unknown

Seoul National University Hospital, Clinical Trial Center, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT04231136 - Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers | Biotech Hunter | Biotech Hunter